Research Article
Mutation of NPM1 and FLT3 Genes in Acute Myeloid Leukemia and Their Association with Clinical and Immunophenotypic Features
Table 3
Immunophenotypic characteristics of AML patients with NPM1 and FLT3/ITD mutations.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
P values were obtained on comparing each of FLT3, NPM1, and FLT3 + NPM1 mutation groups with the no mutation group (column 2). Numbers in the table represent the percentage of positive cases for that antigen marker. *Significant P-value <0.05. #Markers not done in all cases. |